MeQuilibrium has raised $9m in a series B round for its stress-busting resilience programme that uses research from Pennsylvania University.
MeQuilibrium, a US-based company that has created an online stress beating platform based on research carried out at Pennsylvania University, has raised $9m in its series B round.
US-based venture capital firms Safeguard Scientifics and Chrysalis Venture took part in the round along with private investors. Chrysalis also invested in the company’s $2.3m series A round in September 2011 alongside US-based investment company RIME Communications Capital.
MeQuilibrium provides those who use its online service with personalised stress management programmes that build resilience. Its system is based upon research carried out at Pennsylvania University that shows that stress and resilience are linked.
Jan Bruce, chief executive of meQuilibrium, said: “Stress is the #1 threat to employee well-being today – contributing to chronic health conditions, absence, lost productivity and unhealthy lifestyle behaviours. Resilience is the antidote and the unsung hero in the wellness and health continuum. It can impact business in a way that wellness solutions don’t even begin to address. Building individual resilience is the pathway to improved personal performance and to unlocking the collective potential for every company.”
MeQuilibrium plans to use the funding to increase its sales and marketing and expand its product development.
MeQuilibrium’s customers include Comcast and HP.
